Does TESTOSTERONE ENANTHATE Cause Secondary hypogonadism? 7 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Secondary hypogonadism have been filed in association with TESTOSTERONE ENANTHATE (XYOSTED). This represents 0.4% of all adverse event reports for TESTOSTERONE ENANTHATE.
7
Reports of Secondary hypogonadism with TESTOSTERONE ENANTHATE
0.4%
of all TESTOSTERONE ENANTHATE reports
0
Deaths
7
Hospitalizations
How Dangerous Is Secondary hypogonadism From TESTOSTERONE ENANTHATE?
Of the 7 reports, 7 (100.0%) required hospitalization.
Is Secondary hypogonadism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TESTOSTERONE ENANTHATE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does TESTOSTERONE ENANTHATE Cause?
Product dose omission issue (242)
Cerebrovascular accident (226)
Deep vein thrombosis (206)
Pulmonary embolism (194)
Myocardial infarction (187)
Cardiovascular disorder (164)
Pain (150)
Thrombosis (150)
Cardiac failure congestive (136)
Death (131)
What Other Drugs Cause Secondary hypogonadism?
TESTOSTERONE (39)
FINASTERIDE (38)
PREDNISONE (23)
ANASTROZOLE (20)
DUPILUMAB (20)
MIRTAZAPINE (20)
OMALIZUMAB (20)
FLUTICASONE FUROATE (19)
TIOTROPIUM (18)
VILANTEROL (18)
Which TESTOSTERONE ENANTHATE Alternatives Have Lower Secondary hypogonadism Risk?
TESTOSTERONE ENANTHATE vs TESTOSTERONE UNDECANOATE
TESTOSTERONE ENANTHATE vs TETANUS TOXOIDS
TESTOSTERONE ENANTHATE vs TETRABENAZINE
TESTOSTERONE ENANTHATE vs TETRACAINE
TESTOSTERONE ENANTHATE vs TETRACYCLINE